Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Ovarian Neoplasms

Free Subscription Articles published in Int J Oncol Retrieve available abstracts of 26 articles: HTML format Text format

Single Articles

December 2011
1. WANG D , Saga Y, Mizukami H, Sato N, et al
   Indoleamine-2,3-dioxygenase, an immunosuppressive enzyme that inhibits natural killer cell function, as a useful target for ovarian cancer therapy.
   Int J Oncol. 2011 Dec 13. doi: 10.3892/ijo.2011.1295.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. GAO J , Yang X, Yin P, Hu W, et al
   The involvement of FoxO in cell survival and chemosensitivity mediated by Mirk/Dyrk1B in ovarian cancer.
   Int J Oncol. 2011 Dec 12. doi: 10.3892/ijo.2011.1293.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. SORBE B , Graflund M, Nygren L, Horvath G, et al
   A phase II study of docetaxel weekly in combination with carboplatin every three weeks as first line chemotherapy in stage IIB-IV epithelial ovarian cancer: Neurological toxicity and quality-of-life evaluation.
   Int J Oncol. 2011 Dec 7. doi: 10.3892/ijo.2011.1286.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. SHINAGAWA A , Yoshida Y, Kurokawa T, Horiuchi Y, et al
   The potent peptide antagonist to angiogenesis, C16Y, and cisplatin act synergistically in the down-regulation of the Bcl-2/Bax ratio and the induction of apoptosis in human ovarian cancer cells.
   Int J Oncol. 2011;39:1359-64.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. WAGNER BJ , Lob S, Lindau D, Horzer H, et al
   Simvastatin reduces tumor cell adhesion to human peritoneal mesothelial cells by decreased expression of VCAM-1 and beta1 integrin.
   Int J Oncol. 2011;39:1593-600.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
6. KIM KK , Singh AP, Singh RK, Demartino A, et al
   Anti-angiogenic activity of cranberry proanthocyanidins and cytotoxic properties in ovarian cancer cells.
   Int J Oncol. 2011 Sep 12. doi: 10.3892/ijo.2011.1198.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. WEIDERPASS E , Sandin S, Inoue M, Shimazu T, et al
   Risk factors for epithelial ovarian cancer in Japan - results from the Japan Public Health Center-based Prospective Study cohort.
   Int J Oncol. 2011 Sep 8. doi: 10.3892/ijo.2011.1194.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   July 2011
8. AMSTERDAM A , Shezen E, Raanan C, Slilat Y, et al
   Epiregulin as a marker for the initial steps of ovarian cancer development.
   Int J Oncol. 2011 Jul 14. doi: 10.3892/ijo.2011.1123.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   June 2011
9. RAY A , Meng E, Reed E, Shevde LA, et al
   Hedgehog signaling pathway regulates the growth of ovarian cancer spheroid forming cells.
   Int J Oncol. 2011 Jun 22. doi: 10.3892/ijo.2011.1093.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. AMSTERDAM A , Shezen E, Raanan C, Schreiber L, et al
    Nuclear localization of phosphorylated ERK1 and ERK2 as markers for the progression of ovarian cancer.
    Int J Oncol. 2011 Jun 17. doi: 10.3892/ijo.2011.1090.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. MARTINEZ-POVEDA B , Gomez V, Alcaide-German M, Perruca S, et al
    Non-invasive monitoring of hypoxia-inducible factor activation by optical imaging during antiangiogenic treatment in a xenograft model of ovarian carcinoma.
    Int J Oncol. 2011 Jun 9. doi: 10.3892/ijo.2011.1074.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
12. SINGH R , Stockard CR, Grizzle WE, Lillard JW, et al
    Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer.
    Int J Oncol. 2011 May 31. doi: 10.3892/ijo.2011.1059.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
13. ONG PS , Chan SY, Ho PC
    Differential augmentative effects of buthionine sulfoximine and ascorbic acid in As2O3-induced ovarian cancer cell death: Oxidative stress-independent and -dependent cytotoxic potentiation.
    Int J Oncol. 2011 Mar 23. doi: 10.3892/ijo.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. ZHAO S , Ye G, Fu G, Cheng JX, et al
    Ganoderma lucidum exerts anti-tumor effects on ovarian cancer cells and enhances their sensitivity to cisplatin.
    Int J Oncol. 2011 Mar 8. doi: 10.3892/ijo.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
15. KISU I , Banno K, Kobayashi Y, Ono A, et al
    Flexible hysteroscopy with narrow band imaging (NBI) for endoscopic diagnosis of malignant endometrial lesions.
    Int J Oncol. 2011 Jan 14. doi: 10.3892/ijo.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. LOF-OHLIN ZM , Levanat S, Sabol M, Sorbe B, et al
    Promoter methylation in the PTCH gene in cervical epithelial cancer and ovarian cancer tissue as studied by eight novel Pyrosequencing(R) assays.
    Int J Oncol. 2011 Jan 3. doi: 10.3892/ijo.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. NONAKA H , Saga Y, Fujiwara H, Akimoto H, et al
    Indoleamine 2,3-dioxygenase promotes peritoneal dissemination of ovarian cancer through inhibition of natural killercell function and angiogenesis promotion.
    Int J Oncol. 2011;38:113-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
18. LIS R , Capdet J, Mirshahi P, Lacroix-Triki M, et al
    Oncologic trogocytosis with Hospicells induces the expression of N-cadherin by breast cancer cells.
    Int J Oncol. 2010;37:1453-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
19. CICCHILLITTI L , Della Corte A, Di Michele M, Donati MB, et al
    Characterisation of a multimeric protein complex associated with ERp57 within the nucleus in paclitaxel-sensitive and -resistant epithelial ovarian cancer cells: the involvement of specific conformational states of beta-actin.
    Int J Oncol. 2010;37:445-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. JEON HS , Ahn MY, Park JH, Kim TH, et al
    Anticancer effects of the MHY218 novel hydroxamic acid-derived histone deacetylase inhibitor in human ovarian cancer cells.
    Int J Oncol. 2010;37:419-28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. CHAY D , Cho H, Lim BJ, Kang ES, et al
    ER-60 (PDIA3) is highly expressed in a newly established serous ovarian cancer cell line, YDOV-139.
    Int J Oncol. 2010;37:399-412.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
22. BAI T , Tanaka T, Yukawa K
    Targeted knockdown of death-associated protein kinase expression induces TRAIL-mediated apoptosis in human endometrial adenocarcinoma cells.
    Int J Oncol. 2010;37:203-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
23. GORDON EM , Hall FL
    Noteworthy clinical case studies in cancer gene therapy: tumor-targeted Rexin-G advances as an efficacious anti-cancer agent.
    Int J Oncol. 2010;36:1341-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
24. TAMURA T , Kanuma T, Nakazato T, Faried LS, et al
    A new system for regulated functional gene expression for gene therapy applications: nuclear delivery of a p16INK4A-estrogen receptor carboxy terminal fusion protein only in the presence of estrogen.
    Int J Oncol. 2010;36:905-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
25. PASQUINI L , Petronelli A, Petrucci E, Saulle E, et al
    Primary ovarian cancer cells are sensitive to the proaptotic effects of proteasome inhibitors.
    Int J Oncol. 2010;36:707-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2010
26. DAMMANN RH , Kirsch S, Schagdarsurengin U, Dansranjavin T, et al
    Frequent aberrant methylation of the imprinted IGF2/H19 locus and LINE1 hypomethylation in ovarian carcinoma.
    Int J Oncol. 2010;36:171-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: